Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
glp-1 receptor, partial | 1 | 0 | 0 | 1 |
Skn7p | 0 | 0 | 0 | 1 |
ATAD5 protein, partial | 2 | 0 | 0 | 2 |
TDP1 protein | 5 | 0 | 0 | 5 |
apical membrane antigen 1, AMA1 | 3 | 0 | 0 | 3 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
67.9K protein | 2 | 0 | 0 | 2 |
Janus kinase 2 (a protein tyrosine kinase) | 0 | 1 | 0 | 1 |
cellular tumor antigen p53 isoform a | 2 | 0 | 0 | 2 |
chromobox protein homolog 1 | 3 | 0 | 0 | 3 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 3 | 0 | 0 | 3 |
urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
plasminogen precursor | 2 | 0 | 0 | 2 |
urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
survival motor neuron protein isoform d | 3 | 0 | 0 | 3 |
lamin isoform A-delta10 | 3 | 0 | 0 | 3 |
Orotidine 5'-phosphate decarboxylase | 0 | 1 | 0 | 1 |
Orotidine 5'-phosphate decarboxylase | 0 | 1 | 0 | 1 |
Integrin beta-3 | 1 | 0 | 0 | 1 |
Integrin alpha-IIb | 1 | 0 | 0 | 1 |
Alpha-synuclein | 1 | 0 | 0 | 1 |
HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
Chain A, Avidin | 0 | 0 | 1 | 1 |
Chain A, Protein (streptavidin) | 0 | 0 | 1 | 1 |
Chain B, Protein (streptavidin) | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain D, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain D, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain D, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin Complex With Biotin | 0 | 0 | 1 | 1 |
Chain D, Circularly Permuted Core-streptavidin E51/a46 | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Avidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain B, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain B, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 2 | 0 | 0 | 2 |
RAR-related orphan receptor gamma | 3 | 0 | 0 | 3 |
nonstructural protein 1 | 0 | 1 | 0 | 1 |
estrogen nuclear receptor alpha | 5 | 0 | 0 | 5 |
green fluorescent protein, partial | 0 | 1 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
insulin-degrading enzyme isoform 1 | 0 | 0 | 1 | 1 |
Streptavidin | 0 | 0 | 1 | 1 |
Receptor-type tyrosine-protein phosphatase beta | 0 | 0 | 0 | 1 |
interleukin 8 | 1 | 0 | 0 | 1 |
pregnane X receptor | 1 | 0 | 0 | 1 |
Microtubule-associated protein tau | 1 | 0 | 0 | 1 |
AR protein | 5 | 0 | 0 | 5 |
aldehyde dehydrogenase 1 family, member A1 | 2 | 0 | 0 | 2 |
nuclear receptor subfamily 1, group I, member 3 | 3 | 0 | 0 | 3 |
progesterone receptor | 2 | 0 | 0 | 2 |
glucocorticoid receptor [Homo sapiens] | 3 | 0 | 0 | 3 |
retinoic acid nuclear receptor alpha variant 1 | 3 | 0 | 0 | 3 |
retinoid X nuclear receptor alpha | 1 | 0 | 0 | 1 |
estrogen-related nuclear receptor alpha | 4 | 0 | 0 | 4 |
pregnane X nuclear receptor | 2 | 0 | 0 | 2 |
bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
arylsulfatase A | 1 | 0 | 0 | 1 |
IDH1 | 3 | 0 | 0 | 3 |
euchromatic histone-lysine N-methyltransferase 2 | 3 | 0 | 0 | 3 |
nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
Nuclear hormone receptor family member daf-12 | 0 | 0 | 1 | 1 |
thyroid hormone receptor beta isoform 2 | 3 | 0 | 0 | 3 |
serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
oxysterols receptor LXR-beta isoform 1 | 0 | 0 | 1 | 1 |
geminin | 4 | 0 | 0 | 4 |
peripheral myelin protein 22 | 2 | 0 | 0 | 2 |
muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 1 | 0 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 4 | 0 | 6 |
Glutamate receptor 2 | 1 | 2 | 1 | 4 |
Thymidine phosphorylase | 0 | 0 | 0 | 3 |
Thymidylate kinase | 0 | 2 | 0 | 2 |
Nuclear receptor ROR-gamma | 1 | 0 | 0 | 1 |
Spike glycoprotein | 1 | 0 | 0 | 1 |
Thymidine kinase | 0 | 0 | 0 | 3 |
Thymidylate kinase | 0 | 2 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
Ataxin-2 | 2 | 0 | 0 | 2 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 2 | 0 | 0 | 2 |
Thymidine kinase | 0 | 2 | 0 | 3 |
importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
snurportin-1 | 2 | 0 | 0 | 2 |
DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
Vpr | 1 | 0 | 0 | 1 |
TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
Chain A, ADENOSINE DEAMINASE | 0 | 1 | 0 | 1 |
Chain A, ADENOSINE DEAMINASE | 0 | 1 | 0 | 1 |
Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
Smad3 | 1 | 0 | 0 | 1 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 2 | 0 | 0 | 2 |
glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
Purine nucleoside phosphorylase | 0 | 0 | 0 | 1 |
Adenosylhomocysteinase | 0 | 1 | 0 | 2 |
Adenosine deaminase | 0 | 1 | 0 | 1 |
Chain A, Glutamate receptor 2 | 0 | 0 | 1 | 1 |
Chain A, Glutamate receptor 2 | 0 | 0 | 1 | 1 |
Chain C, Glutamate receptor 2 | 0 | 0 | 1 | 1 |
endonuclease IV | 1 | 0 | 0 | 1 |
acetylcholinesterase | 1 | 0 | 0 | 1 |
thioredoxin reductase | 2 | 0 | 0 | 2 |
phosphopantetheinyl transferase | 1 | 0 | 0 | 1 |
GLS protein | 1 | 0 | 0 | 1 |
Bloom syndrome protein isoform 1 | 1 | 0 | 0 | 1 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
Metabotropic glutamate receptor 6 | 0 | 0 | 1 | 1 |
Cellular tumor antigen p53 | 2 | 0 | 0 | 2 |
Glutamate receptor 1 | 0 | 2 | 1 | 3 |
Glutamate receptor 3 | 0 | 2 | 1 | 3 |
Glutamate receptor 4 | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, kainate 1 | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, kainate 1 | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 5 | 0 | 0 | 1 | 1 |
Glutamate receptor ionotropic, kainate 2 | 0 | 2 | 2 | 4 |
Glutamate receptor 1 | 0 | 1 | 1 | 2 |
Glutamate receptor 2 | 0 | 1 | 1 | 2 |
Glutamate receptor 3 | 0 | 0 | 1 | 1 |
Glutamate receptor ionotropic, kainate 3 | 0 | 2 | 0 | 2 |
Glutamate receptor 4 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, kainate 4 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, kainate 2 | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, kainate 3 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, kainate 4 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 5 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, kainate 5 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 1 | 3 |
ATP-dependent phosphofructokinase | 1 | 0 | 0 | 1 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 1 | 0 | 0 | 1 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 2 | 0 | 0 | 2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Thymidylate synthase | 0 | 0 | 0 | 1 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 0 | 0 | 2 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
USP1 protein, partial | 1 | 0 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 1 | 0 | 0 | 1 |
EWS/FLI fusion protein | 1 | 0 | 0 | 1 |
G | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 1 | 0 | 0 | 1 |
peroxisome proliferator activated receptor gamma | 1 | 0 | 0 | 1 |
aryl hydrocarbon receptor | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform a | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 1 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
Interferon beta | 1 | 0 | 0 | 1 |
HLA class I histocompatibility antigen, B alpha chain | 1 | 0 | 0 | 1 |
Transthyretin | 0 | 1 | 0 | 2 |
Thyroid hormone receptor alpha | 0 | 0 | 1 | 1 |
Thyroid hormone receptor beta | 0 | 0 | 1 | 1 |
Proliferating cell nuclear antigen | 0 | 1 | 0 | 1 |
Retinoic acid receptor RXR-alpha | 0 | 0 | 2 | 2 |
UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 2 | 2 |
Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 1 |
Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 1 | 0 | 0 | 1 |
Bile acid receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1B1 | 0 | 0 | 0 | 1 |
cytochrome P450 2C9, partial | 1 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |